1. Clinical factors, psychological factors and beliefs about statin use in patients with coronary heart disease and self-perceived muscle side-effects. (25th November 2020) Authors: Peersen, K; Sverre, E; Kristiansen, O; Fagerland, M; Gullestad, L; Otterstad, J.E; Dammen, T; Munkhaugen, J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease. (25th November 2020) Authors: Munkhaugen, J; Sverre, E; Kristiansen, O; Fagerland, M.W; Peersen, K; Bergan, S; Gullestad, L; Husebye, E; Vethe, N.T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High but not low self-reported statin adherence was confirmed by a novel method based on plasma-statin measurements in coronary outpatients. (11th May 2021) Authors: Kristiansen, O; Sverre, E; Peersen, K; Fagerland, MW; Gjertsen, E; Gullestad, L; Perk, J; Dammen, T; Husebye, E; Vethe, NT; Munkhaugen, J Journal: European journal of preventive cardiology Issue: Volume 28:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low-density lipoprotein cholesterol increased significantly after short-term discontinuation of atorvastatin, but did not correlate with plasma drug concentrations. (11th May 2022) Authors: Sverre, E; Piourevonas, J; Kristiansen, O; Peersen, K; Lauritzen, T; Husebye, E; Fagerland, M; Vethe, NT; Munkhaugen, J Journal: European journal of preventive cardiology Issue: Volume 29(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tailored clinical management after blinded statin challenge improved long-term lipid control in coronary patients with self-perceived muscle side-effects. (11th May 2021) Authors: Sverre, E; Peersen, K; Kristiansen, O; Fagerland, MW; Perk, J; Husebye, E; Vethe, NT; Dammen, T; Munkhaugen, J Journal: European journal of preventive cardiology Issue: Volume 28:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗